In June 2023, Paul Skye Lehrman and his partner Linnea Sage were driving near their home in New York City, listening to a podcast about the ongoing strikes in Hollywood and how artificial intelligence (AI) could affect the industry.

The episode was of interest because the couple are voice-over performers and - like many other creatives - fear that human-sounding voice generators could soon be used to replace them.

This particular podcast had a unique hook – they interviewed an AI-powered chat bot, equipped with text-to-speech software, to ask how it thought the use of AI would affect jobs in Hollywood.

But, when it spoke, it sounded just like Mr Lehrman.

That night they spent hours online, searching for clues until they came across the site of text-to-speech platform Lovo. Once there, Ms Sage said she found a copy of her voice as well.

They have now filed a lawsuit against Lovo. The firm has not yet responded to that or the BBC’s requests for comment.

  • VirtualOdour
    link
    fedilink
    English
    arrow-up
    2
    arrow-down
    6
    ·
    4 months ago

    Why do you say instead of when describing something that exists and is available? It’s not even expensive.

    I think what you mean is why is all the focus always on negative uses and never positive and that’s because you’re on a website with a hate boner for technology, especially ai.

    • curbstickle@lemmy.dbzer0.com
      link
      fedilink
      English
      arrow-up
      5
      arrow-down
      1
      ·
      4 months ago

      Because this is where the money is universally going, and no, its not “readily available” for most.

      I can do it.

      ALS patients and their families, in terms of what’s covered, are getting mostly the same as what was available 5-10 years ago. This isn’t about focusing on the negative, this is just where things are right now. Services to recreate a voice for tts to folks with ALS or similar issues are insanely expensive, to the point of being exploitative.

      So I say it because its the truth.